Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Second case of Brucella canis in the UK
'The case highlights again the need for veterinary professionals to be alert to the possibility of potentially zoonotic B canis in dogs.'
Affected dog was imported from Bosnia

The Animal and Plant Health Agency (APHA) has confirmed a second UK case of Brucella canis in a dog imported from Eastern Europe.

A male dog, aged around five months, was imported from Bosnia in November 2015 and presented with reluctance to move, stilted hindlimb gait and intermittent lameness in October last year.

After two positive results on serological testing for B canis in March 2017, the APHA confirmed B canis by phenotypic and molecular approaches. Writing in Vet Record letters, the APHA said the dog is undergoing an eight-week course of doxycycline, with a good response so far.

This case is the second to be confirmed in the UK this year. A rescue dog imported from Romania and adopted in January 2016 was later presented to a veterinary practice in Leicestershire. It was showing intermittent signs of pain when rising from a sitting position and lesions consistent with diskospondylitis were detected via radiography.

Signs resolved after antibiotic treatment but recurred after treatment stopped, with a gradual deterioration of the dog’s overall health. Earlier this year, testing at APHA Weybridge confirmed B canis.

The organism was not previously thought to be present in the UK.

APHA wrote in Vet Record: ‘The case highlights again the need for veterinary professionals to be alert to the possibility of potentially zoonotic B canis in dogs, and particularly in imported animals, with reproductive or chronic inflammatory disease.’

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.